Cancer initiation by fumonisin B(1) in rat liver--role of cell proliferation

• Published in: Cancer letters Vol. 169; no. 2; p. 127
• Main Authors: Gelderblom, W C, Galendo, D, Abel, S, Swanevelder, S, Marasas, W F, Wild, C P
• Format: Journal Article
• Language: English
• Published: Ireland 28-08-2001
• Subjects: 2-Acetylaminofluorene - pharmacology; Animals; Carbon Tetrachloride - pharmacology; Carboxylic Acids; Carcinogens; Cell Division; Dose-Response Relationship, Drug; Fumonisins; Hepatocytes - metabolism; Lipid Peroxidation - drug effects; Liver - drug effects; Male; Neoplasms - chemically induced; Rats; Rats, Inbred F344; Thiobarbituric Acid Reactive Substances - metabolism; Time Factors
• ISSN: 0304-3835

Fumonisin B(1) (FB(1)), a carcinogenic mycotoxin produced by the fungus Fusarium verticillioides in corn, causes cancer initiation in rat liver in a similar manner to genotoxic carcinogens although apparently with different kinetics. The present experiment was designed to evaluate the role of regenerative cell proliferation, effected by partial hepatectomy (PH) and carbontetrachloride (CCl(4)) and direct mitogen-induced hyperplasia, induced by lead nitrate (PbNO(3)), on FB(1)-induced cancer initiation. Initiation was effected over a period of 14 days by gavage administration of FB(1) at different daily doses ranging from 0.14 to 3.5 mg FB(1)/100 g body weight while the stimuli for cell proliferation were introduced 7 days after the start of the FB(1) treatment. Based on the proliferative stimulus used, cancer promotion was effected 3 weeks after completion of the initiating treatment by 2-acetylaminofluorene (2-AAF) treatment followed by PH or carbon tetrachloride CCl(4) on day 4. Cancer initiation by FB(1) was associated with a hepatotoxic effect and an increase in lipid peroxidation. In contrast to compensatory liver cell proliferation induced by PH and CCl(4), mitogen-induced hyperplasia (PbNO(3)) failed to enhance the cancer initiating potential of FB(1) suggesting that cancer induction by a non-genotoxic carcinogen is supported by regenerative cell proliferation. Cognizance of the enhancing role of cell proliferation during cancer initiation by FB(1) is required in assessing the risks posed by this mycotoxin to humans.